Clik here to view.
Tandem Diabetes closes $23m offering
Tandem Diabetes Care (NSDQ:TNDM) said yesterday it closed a $23.1 million round of funding. In the offering, San Diego-based Tandem Diabetes floated approximately 18.5 million shares of common stock at...
View ArticleClik here to view.
Cardiovascular Systems launches combined Diamondback 360, DES trial
Cardiovascular Systems (NSDQ:CSII) said today it enrolled the 1st patient in the Eclipse clinical trial of its Diamondback 360 coronary orbital atherectomy system. The St. Paul, Minn.-based company is...
View ArticleClik here to view.
Integer CEO Hook steps down | Personnel Moves – March 29, 2017
Integer Holdings (NYSE:ITGR) said this week that current CEO Thomas Hook has stepped down as the company’s president and CEO, effective immediately, with Joseph Dziedzic taking over as interim prez...
View ArticleClik here to view.
Siemens Medical wins $4B DoD radiology supply contract
Siemens (NYSE:SI) Healthineers healthcare division won a maximum $4 billion contract with the US Department of Defense, according to a DoD release. The 5-year deal is a firm-fixed-price, indefinite...
View ArticleClik here to view.
FDA launches Experimental Learning Program
By Stewart Eisenhart, Emergo Group The US Food and Drug Administration is rolling out a new program whereby regulatory staff learn about new and innovative medical device technologies from industry to...
View ArticleClik here to view.
Boston Scientific puts up $435m for Symetis just ahead of IPO
Boston Scientific (NYSE:BSX) is putting up $435 million in cash for Symetis and its line of minimally invasive replacement heart valves, the companies said today. The buyout halts the 2nd run at an...
View ArticleClik here to view.
Acorda plans NDA for inhaled Parkinson’s drug after touting long-term safety...
Acorda Therapeutics (NSDQ:ACOR) touted data from 2 ongoing, long-term safety studies of its inhaled Parkinson’s therapy. The trials showed no difference in pulmonary function between the group...
View ArticleClik here to view.
Not so fast: Utah’s Hatch thinks medtech levy repeal could still be part of...
Despite House Republicans’ insistence that any taxes associated with Obamacare – including the medical device tax – won’t be part of the negotiations over tax reform, Sen. Orrin Hatch (R-Utah) that the...
View ArticleClik here to view.
Aura Biosciences wins fast track designation for light-activated nanoparticle...
Aura Biosciences said today that it enrolled and dosed the 1st patient in the Phase Ib trial of its light-activated AU-011 viral nanoparticle conjugate therapy for the treatment of ocular melanoma. The...
View ArticleClik here to view.
ConvaTec expands Unomedical infusion set biz for Medtronic
ConvaTec (LON:CTEC) said today that it’s expanding its Unomedical infusion set business to keep pace with the diabetes segment at Medtronic (NYSE:MDT). The British wound care and colostomy supplies...
View ArticleClik here to view.
Capsugel expands into late-stage inhalation delivery
Capsugel said today that it expanded its late-stage inhalation formulation capabilities to move dry powder inhalation concepts through late-stage clinical trial and into commercial production. The...
View ArticleClik here to view.
ADM Cleveland: Here are some top medtech manufacturing highlights
The inaugural Advanced Design and Manufacturing is showcasing some of the medical device industry’s top design and manufacturing technology this week at the Huntington Convention Center in Cleveland,...
View ArticleClik here to view.
SteadyMed reels in losses with Q4 earnings
Shares in SteadyMed (NSDQ:STDY) rose yesterday after the pharmaceutical company reported its 4th quarter results. The San Ramon, Calif.-based company posted losses of -$2.4 million, or -12¢ per share,...
View ArticleClik here to view.
Samsung Biologics slides on South Korean regulatory probe
News that Samsung Biologics is facing a probe by South Korean regulators over its valuation ahead of an initial public offering last year sent its share price down this week in Seoul. South Korea’s...
View ArticleClik here to view.
Incoming AdvaMed chairman Yared: We’ll take medtech tax repeal ‘in any form’
Medtech industry lobbying group AdvaMed will maintain its focus on pursuing a full repeal of the medical device tax, no matter what form the repeal takes, according to newly appointed AdvaMed chair...
View ArticleClik here to view.
Medtronic launches Arctic Front cryoablation PVI study
Medtronic (NYSE:MDT) said today it enrolled the 1st patient in the Stop Persistent AF clinical trial of its Arctic Front Advance cardiac cryoablation catheter. The 225-patient, 12-month trial aims to...
View ArticleClik here to view.
Biotronik touts doctors’ survey responses for Magmaris drug-eluting scaffold
Biotronik touted data today from its Magnesium 1,000 program, which provided doctors with an early post-market opportunity to evaluate the company’s new resorbable Magmaris magnesium scaffold. More...
View ArticleClik here to view.
Abiomed doubles Danvers footprint
Abiomed (NSDQ:ABMD) today opened its expanded headquarters in Danvers, Mass., which more than doubles its footprint in the Bay State. Gov. Charlie Baker helped Abiomed CEO Mike Minogue and patient...
View ArticleClik here to view.
Merck, Avillion ink development deal for nanobody psoriasis treatment
Merck KGaA and Avillion inked a clinical co-development deal today for Merck’s anti IL-17 A/F Nanobody therapy for plaque psoriasis. The financial terms of the deal were not disclosed. The...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for March 30, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View Article
